Partner Content Partner Content Four Key Reasons to Attend SMi's 2019 Biosimilars Conference Four Key Reasons to Attend SMi's 2019 Biosimilars
Partner Content Partner Content 10 Key Reasons to attend SMi’s 10th Annual Biosimilars Confe... 10 Key Reasons to attend Biosimilars
Partner Content Partner Content Michel Mikhail invites Biosimilar experts to attend SMi’s 10... Michel Mikhail invites Biosimilar experts to attend SMi
Events Partner Content SMi’s 10th Annual Biosimilars Conference Biosimilars Conference, London, Sept 2019
Partner Content Partner Content Save the date for SMi’s 10th Annual Biosimilars Conference 2... Save the date for SMi’s 10th Annual Biosimilars Conf
Partner Content Partner Content SMi’s release speaker interview Anita Burrell, speaker at Bi... Biosimilars USA conference information
News Gilead claims first FDA nod for a hepatitis D therapy At its second attempt, Gilead has won FDA approval for chronic hepatitis D virus drug Hepcludex, four years after it was cleared in the EU.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
